Acadia Healthcare Company, Inc. (NASDAQ:ACHC) was the recipient of a significant decline in short interest in the month of September. As of September 29th, there was short interest totalling 17,773,953 shares, a decline of 14.3% from the September 15th total of 20,744,872 shares. Currently, 21.0% of the company’s shares are sold short. Based on an average daily volume of 654,559 shares, the days-to-cover ratio is currently 27.2 days.

A number of analysts have recently issued reports on ACHC shares. Jefferies Group LLC set a $60.00 target price on shares of Acadia Healthcare and gave the company a “buy” rating in a research note on Wednesday, October 11th. BidaskClub lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Friday, August 18th. Zacks Investment Research lowered shares of Acadia Healthcare from a “buy” rating to a “hold” rating in a research note on Tuesday, August 1st. William Blair started coverage on shares of Acadia Healthcare in a research note on Tuesday, July 18th. They set an “outperform” rating for the company. Finally, Deutsche Bank AG boosted their target price on shares of Acadia Healthcare from $58.00 to $60.00 and gave the company a “buy” rating in a research note on Monday, July 31st. Two research analysts have rated the stock with a sell rating, two have given a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $56.91.

In other news, Director Reeve B. Waud sold 1,240,000 shares of the business’s stock in a transaction on Monday, July 31st. The shares were sold at an average price of $51.72, for a total transaction of $64,132,800.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director William Grieco sold 2,000 shares of the business’s stock in a transaction on Friday, August 11th. The shares were sold at an average price of $51.71, for a total transaction of $103,420.00. Following the sale, the director now directly owns 45,013 shares of the company’s stock, valued at $2,327,622.23. The disclosure for this sale can be found here. Insiders have sold 3,085,693 shares of company stock valued at $157,729,099 over the last three months. Insiders own 11.10% of the company’s stock.

Institutional investors have recently made changes to their positions in the stock. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in Acadia Healthcare by 11.1% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,704 shares of the company’s stock valued at $134,000 after acquiring an additional 270 shares during the period. C M Bidwell & Associates Ltd. purchased a new position in Acadia Healthcare during the 2nd quarter valued at about $205,000. Riverhead Capital Management LLC purchased a new position in Acadia Healthcare during the 2nd quarter valued at about $209,000. World Asset Management Inc purchased a new position in Acadia Healthcare during the 2nd quarter valued at about $242,000. Finally, Paloma Partners Management Co purchased a new position in Acadia Healthcare during the 1st quarter valued at about $217,000.

Shares of Acadia Healthcare (NASDAQ ACHC) opened at 41.81 on Wednesday. Acadia Healthcare has a 1-year low of $32.54 and a 1-year high of $54.34. The company has a 50-day moving average of $46.12 and a 200-day moving average of $46.36. The stock has a market capitalization of $3.67 billion, a price-to-earnings ratio of 459.45 and a beta of 1.07.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Thursday, July 27th. The company reported $0.66 EPS for the quarter, beating analysts’ consensus estimates of $0.65 by $0.01. Acadia Healthcare had a return on equity of 8.69% and a net margin of 0.30%. The company had revenue of $715.90 million during the quarter, compared to analysts’ expectations of $717.38 million. During the same period last year, the business posted $0.73 EPS. Acadia Healthcare’s revenue for the quarter was down 5.4% on a year-over-year basis. On average, equities research analysts expect that Acadia Healthcare will post $2.44 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This news story was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2017/10/18/acadia-healthcare-company-inc-achc-short-interest-down-14-3-in-september.html.

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Receive News & Stock Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related stocks with our FREE daily email newsletter.